350 related articles for article (PubMed ID: 19737291)
1. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness.
Seidler AM; Bramlette TB; Washington CV; Szeto H; Chen SC
Dermatol Surg; 2009 Nov; 35(11):1776-87. PubMed ID: 19737291
[TBL] [Abstract][Full Text] [Related]
2. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
6. [Cost analysis of Mohs micrographic surgery in high-risk facial basal cell carcinoma].
Blázquez-Sánchez N; de Troya-Martín M; Frieyro-Elicegui M; Fúnez-Liébana R; Martín-Márquez L; Rivas-Ruiz F
Actas Dermosifiliogr; 2010 Sep; 101(7):622-8. PubMed ID: 20858388
[TBL] [Abstract][Full Text] [Related]
7. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
8. Quality of life assessment in nonmelanoma cervicofacial skin cancer.
Rhee JS; Loberiza FR; Matthews BA; Neuburg M; Smith TL; Burzynski M
Laryngoscope; 2003 Feb; 113(2):215-20. PubMed ID: 12567071
[TBL] [Abstract][Full Text] [Related]
9. Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL; Meisner BC; Frick KD; Armstrong DK
Cancer; 2007 Apr; 109(8):1513-22. PubMed ID: 17354232
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
Cumberland L; Dana A; Liegeois N
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
[TBL] [Abstract][Full Text] [Related]
12. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
13. Eighteen years of experience in Mohs micrographic surgery and conventional excision for nonmelanoma skin cancer treated by a single facial plastic surgeon and pathologist.
van der Eerden PA; Prins ME; Lohuis PJ; Balm FA; Vuyk HD
Laryngoscope; 2010 Dec; 120(12):2378-84. PubMed ID: 21046543
[TBL] [Abstract][Full Text] [Related]
14. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
Lear W; Mittmann N; Barnes E; Breen D; Murray C
J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
[TBL] [Abstract][Full Text] [Related]
15. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
[TBL] [Abstract][Full Text] [Related]
16. Surgical decision making for basal-cell carcinoma of the face.
Feldman S; Pearce DJ; Williford PM
Lancet Oncol; 2008 Dec; 9(12):1119-20. PubMed ID: 19038758
[No Abstract] [Full Text] [Related]
17. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis: Mohs micrographic surgery.
Ravitskiy L; Brodland DG; Zitelli JA
Dermatol Surg; 2012 Apr; 38(4):585-94. PubMed ID: 22443180
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face.
Otley CC
Arch Dermatol; 2006 Sep; 142(9):1235; author reply 1235-6. PubMed ID: 16983019
[No Abstract] [Full Text] [Related]
20. Unit cost of Mohs and Dermasurgery Unit.
Wanitphakdeedecha R; Nguyen TH; Chen TM
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):445-8. PubMed ID: 19744256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]